Tribiano, Italy

Acs Dobfar S.p.a.


USPTO Granted Patents = 16

% Expired Patents = 50.0



Trademarks = 5

Forward Citations = 80

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Maurizio Zenoni (11 out of 14 patents)

silverMedal Leonardo Marsili (6 out of 6 patents)

bronzeMedal Antonio Manca (5 out of 5 patents)

4.  Riccardo Monguzzi (5 out of 5 patents)

5.  Angelo Giovanni Cattaneo (4 out of 4 patents)

6.  Giovanni Fogliato (3 out of 14 patents)

7.  Mario Leone (3 out of 3 patents)

8.  Marco Falciani (2 out of 12 patents)

9.  Marco Forzatti (1 out of 3 patents)

10.  Sergio Dusci (1 out of 5 patents)

11.  Giuseppe Alessandro Donadelli (1 out of 5 patents)

12.  Mauro Freccero (1 out of 1 patent)

13.  Michele Bassanini (1 out of 1 patent)

14.  Gabriele Guastalegname (1 out of 1 patent)

15.  Alessandro Donadelli (1 out of 2 patents)


16 patents:

Company Overview
Acs Dobfar S.p.a. is a prominent player in the pharmaceutical sector, specializing in the development and manufacturing of advanced drug delivery systems. The company focuses on innovative solutions that enhance the efficacy and safety of medications, catering to various therapeutic areas. With a strong emphasis on research and development, Acs Dobfar is committed to leveraging cutting-edge technologies to meet the evolving needs of healthcare providers and patients, primarily serving markets in Europe and beyond.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

16 Patents

#1 in Tribiano

#578 in Italy

#37,788 in the World

Tribiano, IT
Tribiano, Italy
Forward Citations = 80

18 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Acs Dobfar S.p.a.. Retrieved from https://idiyas.com/company/acs-dobfar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…